Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human coagulation factor VIII in hemophilia A
CTR20182045Phase 3Completed
- Sponsor
- Shenzhen Weiguang Biological Products
- Start
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of antihemophilic factor human in hemophilia A, sponsored by Shenzhen Weiguang Biological Products. Started Nov 2018; status: completed.
02
Drugs
antihemophilic factor human
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20182045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182045.